Caxton Associates (New York)’s Corteva CTVA Stock Holding History
Bought
Maintained
Sold
Other funds holding CTVA
IFP
N
Caxton Associates (New York)'s CTVA Position: Q1 2024 in Review
Caxton Associates (New York) sold out of Corteva (CTVA) in Q1 2024, closing a stake of 23,948 shares — an estimated $1.15M sold.
Caxton Associates (New York) first reported a position in CTVA in Q3 2021 and held it in 3 quarters. The position peaked at $1.15M in Q4 2023. 1,260 funds tracked by Wall St. Rank hold CTVA as of Q1 2024.
- Caxton Associates (New York) reported no remaining Corteva position as of Q1 2024 after selling out during the quarter.
- Caxton Associates (New York) sold 23,948 Corteva shares in Q1 2024, an estimated $1.15M.
- Caxton Associates (New York) first reported a position in Corteva in Q3 2021 and held it in 3 quarters.
- Caxton Associates (New York)'s Corteva position peaked at $1.15M in Q4 2023.
- 1,260 funds tracked by Wall St. Rank held Corteva as of Q1 2024.
Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.